1. US Food and Drug Administration. Guidance for industry: premarketing risk assessment. March 2005. Available at: https://www.fda.gov/media/71650/download. Accessed January 11, 2023.
2. The art and science of risk management: a US research-based industry perspective;Bush;Drug Saf,2005
3. US Food and Drug Administration. Guidance for industry: development and use of risk minimization action plans. March 2005. Available at: https://www.fda.gov/media/71268/download. Accessed January 11, 2023.
4. Pharmacovigilance: an overview;Beninger;Clin Ther,2018
5. Pharmacovigilance during the pre-approval phases: an evolving pharmaceutical industry model in response to ICH E2E, CIOMS VI, FDA and EMEA/CHMP risk-management guidelines;Hartford;Drug Saf,2006